Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...

PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...

ATLANTA — Arcapita Ventures announced today that CardioMEMS, Inc. has received U.S. FDA (Food and Drug Administration) approval for its Heart Failure Management System. The approval is based upon the ...

PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...

PHILADELPHIA (WPVI) -- Heart failure is one of the most common reasons why seniors end up in the hospital. But a tiny, new device is helping to prevent that. Congestive heart failure can be very ...

Please provide your email address to receive an email when new articles are posted on . In late May, the FDA approved the CardioMEMS HF System for the measurement of pulmonary artery pressure and ...

The FDA's Circulatory System Devices Panel sent a mixed message to the FDA today about CardioMEMS Champion HF Pressure Measurement System. The small implantable device provides provides daily ...

CardioMEMS, a member of Georgia Tech’s Advanced Technology Development Center (ATDC), is pioneering a new breed of testing devices to monitor heart patients. Combining wireless communications ...

As Abbott seeks an expanded indication for its CardioMEMS device for patients with heart failure, it’s also hoping to win over a national coverage decision from the Centers for Medicare and Medicaid ...

The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...

St. Jude Medical Inc., a medical device company, said it plans to exercise an option to acquire all of Atlanta-based CardioMEMS now that CardioMEMS’ heart failure monitoring device has received U.S.

Global medical device company, St. Jude Medical Inc. ( STJ) completed its acquisition of privately-held CardioMEMS, Inc. - the developer of the CardioMEMS Heart Failure (HF) System. The buyout ...